Akers Biosciences, Inc. | Business Contracts

Amendment No. 2 to Employment Agreement between Paul Rivard and MyMD Pharmaceuticals (Florida), Inc., dated December 18, 2020 (Filed With SEC on May 18, 2021)

Asset Purchase Agreement, dated November 11, 2020, by and between MyMD Pharmaceuticals, Inc. and Supera Pharmaceuticals, Inc (Filed With SEC on May 18, 2021)

Description of Securities (Filed With SEC on March 1, 2021)

Form of Voting Agreement, by and between MYMD Pharmaceuticals, Inc. and the directors, officers and certain stockholders of Akers Biosciences, Inc (Filed With SEC on November 12, 2020)

Agreement and Plan of Merger and Reorganization, dated November 11, 2020, by and among Akers Biosciences, Inc., XYZ Merger Sub Inc., and MYMD Pharmaceuticals, Inc (Filed With SEC on November 12, 2020)

License Agreement (Filed With SEC on March 24, 2020)

Amendment No. 1 to Employment Agreement between Adam Kaplin and MyMD Pharmaceuticals (Florida), Inc, dated February 11, 2021 (Filed With SEC on May 18, 2021)

Amended and Restated Confirmatory Patent Assignment and Royalty Agreement dated November 11, 2020, by and between SRQ Patent Holdings II, LLC and Supera Pharmaceuticals, Inc (Filed With SEC on May 18, 2021)

Amended and Restated Confirmatory Patent Assignment and Royalty Agreement dated November 11, 2020, by and between SRQ Patent Holdings, LLC and MyMD Pharmaceuticals, Inc (Filed With SEC on May 18, 2021)

Employment Agreement between Adam Kaplin and MyMD Pharmaceuticals (Florida), Inc., effective December 18, 2020 (Filed With SEC on May 18, 2021)

MyMD Pharmaceuticals (Florida) Inc. Second Amendment to Amended and Restated 2016 Stock Incentive Plan, dated July 1, 2019 (Filed With SEC on May 18, 2021)

Employment Agreement between Chris Chapman and MyMD Pharmaceuticals (Florida), Inc., effective November 1, 2020 (Filed With SEC on May 18, 2021)

Amendment No. 1 to Employment Agreement between Chris Chapman and MyMD Pharmaceuticals (Florida), Inc., dated December 18, 2020 (Filed With SEC on May 18, 2021)

Amendment No. 2 to Employment Agreement between Chris Chapman and MyMD Pharmaceuticals (Florida), Inc., dated January 8, 2021 (Filed With SEC on May 18, 2021)

Amendment No. 3 to Employment Agreement between Chris Chapman and MyMD Pharmaceuticals (Florida), Inc., dated February 11, 2021 (Filed With SEC on May 18, 2021)

Employment Agreement between Paul Rivard and MyMD Pharmaceuticals (Florida), Inc., dated September 21, 2020 (Filed With SEC on May 18, 2021)

Amendment No. 1 to Employment Agreement between Paul Rivard and MyMD Pharmaceuticals (Florida), Inc., dated November 24, 2020 (Filed With SEC on May 18, 2021)

MyMD Pharmaceuticals, Inc. 2021 Equity Incentive Plan (Filed With SEC on April 22, 2021)

Form of Nonqualified Stock Option Agreement (Filed With SEC on April 22, 2021)

Form of Incentive Stock Option Agreement (Filed With SEC on April 22, 2021)

Form of Restricted Stock Award Agreement (Filed With SEC on April 22, 2021)

Form of Placement Agent Warrant (Filed With SEC on November 18, 2020)

Form of Pre-Funded Warrant. of Akers Biosciences, Inc (Filed With SEC on November 12, 2020)

Form of Lock-Up and Support Agreement, dated November 11, 2020, by and between Akers Biosciences, Inc. and its stockholders named therein (Filed With SEC on November 12, 2020)

Form of Securities Purchase Agreement, dated November 11, 2020, by and between Akers Biosciences, Inc. and purchasers named therein (Filed With SEC on November 12, 2020)

The Secured Promissory Note, dated November 11, 2020, by and between Akers Biosciences, Inc. and MYMD Pharmaceuticals, Inc (Filed With SEC on November 12, 2020)

Form of Lock-Up/Leak-Out Agreement (Filed With SEC on November 12, 2020)

Form of Investor Warrant. of Akers Biosciences, Inc (Filed With SEC on November 12, 2020)

Form of Voting Agreement, by and between Akers Biosciences, Inc. and the directors, officers and certain specified stockholders of MyMD Pharmaceuticals, Inc (Filed With SEC on November 12, 2020)

Rights Agreement dated as of September 9, 2020 between Akers Biosciences, Inc. and VStock Transfer, LLC as Rights Agent (Filed With SEC on September 9, 2020)

Akers Biosciences, Inc. 2018 Plan Amendment (Filed With SEC on August 28, 2020)

Form of Securities Purchase Agreement (Filed With SEC on August 13, 2020)

Form of Placement Agent Warrant (Filed With SEC on August 13, 2020)

Leak-Out and Support Agreement, dated as of August 3, 2020, by and among Akers Biosciences, Inc. and ChubeWorkx Guernsey Limited (Filed With SEC on August 10, 2020)

Settlement Agreement and General Release, dated as of August 3, 2020, by and among Akers Biosciences, Inc. and ChubeWorkx Guernsey Limited (Filed With SEC on August 10, 2020)

CFO Consulting Agreement, dated as of July 21, 2020, between Akers Biosciences, Inc. and Brio Financial Group (Filed With SEC on July 22, 2020)

Amendment No. 1 to the Membership Interest Purchase Agreement, dated May 14, 2020 (Filed With SEC on May 15, 2020)

Form of Securities Purchase Agreement (Filed With SEC on May 15, 2020)

Form of Placement Agent Warrant (Filed With SEC on May 15, 2020)

Form of Securities Purchase Agreement (Filed With SEC on April 8, 2020)

Form of Placement Agent Warrant (Filed With SEC on April 8, 2020)

Description of Securities (Filed With SEC on March 25, 2020)

Registration Rights Agreement (Filed With SEC on March 24, 2020)

Support Agreement (Filed With SEC on March 24, 2020)

Membership Interest Purchase Agreement (Filed With SEC on March 24, 2020)

Executive Chairman Agreement, dated January 31, 2020 (Filed With SEC on January 31, 2020)

Offer of Employment, dated January 6, 2020 (Filed With SEC on January 6, 2020)

Form of Placement Agent Warrant Certificate (Filed With SEC on November 29, 2019)

Form of Pre-Funded Warrant Certificate (Filed With SEC on November 29, 2019)

Form of Securities Purchase Agreement (Filed With SEC on November 29, 2019)

Form of Series C Convertible Preferred Stock Warrant Certificate (Filed With SEC on November 29, 2019)

Akers Biosciences, Inc. (51)